Cipla’s manufacturing facility in Goa gets VAI classification
The US FDA conducted a cGMP inspection between June 10-21, 2024
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
CGMP
Eugia gets USFDA warning letter for Unit-3 in Pashamylaram
Eugia Pharma is a wholly-owned subsidiary of Hyderabad-based drug manufacturer, Aurobindo Pharma
US FDA issues warning letter to Lupin for Maharashtra-based API plant
The FDA inspected the manufacturing facility from 22nd March to 4th April, 2022
Macleods Pharmaceuticals recalls products in US due to manufacturing issues
According to the latest enforcement report issued by the US FDA, the US-based arm of the drug firm is recalling 3,672 bottles of…
Five institutions come together to organise virtual workshops series on GMP
The workshop series was conducted by the Ministry of Health, along with the Ministry of Chemicals and Fertilizers, the World…
Health Ministry, WHO, JSS AHER, IPA and partners organise series of virtual workshops on GMP
Under this initiative, a total of six workshops are being conducted - two for formulation manufacturing pharma units, three for…
Lupin, Granules India recall around 9.71 lakh bottles of diabetes drug in the US
Various companies across the globe have announced similar recalls for the product after the USFDA pointed out the presence of NDMA…
JB Chemicals Gujarat unit passes US FDA inspection with one observation
The company proposes to address this observation in the next 15 days
JB Chemicals and Pharmaceuticals said its Gujarat unit has…
A paradigm shift to achieve quality initiatives throughout the manufacturing process
Amit Chopra, Managing Director, India and Middle East, Thermo Fisher Scientific highlights the need to ensure quality of materials…
USFDA pulls up Lantech Pharma for manufacturing violations at Andhra plant
The significant violations included the failure of the quality unit to ensure that quality-related complaints were investigated…